Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.

PURPOSE Neuropathic pain is an unavoidable treatment-related adverse event among patients with head and neck cancer who are undergoing radiotherapy. We aimed to test the efficacy and safety of pregabalin versus placebo in the treatment of radiotherapy-related neuropathic pain. PATIENTS AND METHODS This randomized, double-blind, placebo-controlled trial was conducted in four centers in China. Eligible patients with a mean pain intensity score of 4 or more on an 11-point numeric rating scale were randomly assigned to receive either active treatment with a flexible dose of pregabalin or placebo for 16 weeks. The primary efficacy outcome was pain reduction measured on the numeric rating scale. RESULT There were 128 patients who received treatment as randomly assigned. Pain intensity reduction was 2.44 in the pregabalin arm and 1.58 in the placebo arm at week 16, yielding an adjusted mean difference of 0.87 (95% CI, 0.30 to 1.44; P = .003). In the pregabalin arm, 38 patients (59.4%) achieved at least 30% pain relief versus 21 (32.8%) in the placebo arm ( P = .006). Nineteen patients (29.7%) in the pregabalin group and five (7.8%) in the placebo group achieved 50% or greater pain relief ( P = .003). Total scores on the Profile of Mood States-Short Form, pain severity and functional interference of Brief Pain Inventory-Short Form, as well as the physiology and psychology domain of the WHO Quality of Life-BREF all were reduced significantly at week 16 in patients who received pregabalin compared with those who received placebo. There was no significant difference ( P = .29) in the incidence of experiencing at least one adverse event in the pregabalin arm (n = 35; 54.7%) versus the placebo arm (n = 29; 45.3%). CONCLUSION Patients treated with pregabalin with radiotherapy-related neuropathic pain had greater pain alleviation, better mood states, and higher quality of life compared with patients in the placebo group, with a good tolerability.

[1]  M. Ghiani,et al.  Is pain part of a systemic syndrome in head and neck cancer? , 2019, Supportive Care in Cancer.

[2]  Axel Benner,et al.  Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis , 2016, Nature Communications.

[3]  Yi Li,et al.  Radiation-induced brachial plexopathy in patients with nasopharyngeal carcinoma: a retrospective study , 2016, Oncotarget.

[4]  Christine Miaskowski,et al.  Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy , 2015, Pain.

[5]  C. Cleeland,et al.  The symptom burden of treatment‐naive patients with head and neck cancer , 2015, Cancer.

[6]  D. Simpson,et al.  A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy , 2014, PAIN®.

[7]  J. Frampton.  Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder , 2014, CNS Drugs.

[8]  A. Peltier,et al.  Painful diabetic neuropathy. , 2014, BMJ.

[9]  T. Phillips,et al.  Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol. , 2014, International journal of radiation oncology, biology, physics.

[10]  M. Daly,et al.  Depression among long-term survivors of head and neck cancer treated with radiation therapy. , 2013, JAMA otolaryngology-- head & neck surgery.

[11]  M. Fallon,et al.  Neuropathic pain in cancer. , 2013, British journal of anaesthesia.

[12]  J. Lefaix,et al.  Radiation-induced neuropathy in cancer survivors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  J. Thariat,et al.  Oral complications of cancer and cancer therapy , 2012, CA: a cancer journal for clinicians.

[14]  K. Hau,et al.  Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF , 2012, BMC Medical Research Methodology.

[15]  V. López-Gómez,et al.  Prevalence of neuropathic pain in radiotherapy oncology units. , 2011, International journal of radiation oncology, biology, physics.

[16]  T. Hedberg,et al.  Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect. , 2010, The journal of pain : official journal of the American Pain Society.

[17]  J. Yarnold,et al.  Pathogenetic mechanisms in radiation fibrosis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  G. Weinstein,et al.  Gabapentin for the treatment of pain syndrome related to radiation‐induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy , 2010, Cancer.

[19]  J. Farrar,et al.  Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations , 2009, PAIN.

[20]  J. Epstein,et al.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy , 2009, Head & neck oncology.

[21]  David Cella,et al.  Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.

[22]  Michael G Kenward,et al.  Multiple imputation: current perspectives , 2007, Statistical methods in medical research.

[23]  R. Dworkin,et al.  The impact of neuropathic pain on health-related quality of life , 2007, Neurology.

[24]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[25]  J. Rosenstock,et al.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.

[26]  J. Bolton,et al.  Assessing the clinical significance of change scores recorded on subjective outcome measures. , 2004, Journal of manipulative and physiological therapeutics.

[27]  S. Huson,et al.  Radiation-induced brachial plexopathy in women treated for carcinoma of the breast , 2002, Clinical rehabilitation.

[28]  S H Ferris,et al.  Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.

[29]  C. Cleeland,et al.  The chinese version of the brief pain inventory (BPI-C): its development and use in a study of cancer pain , 1996, Pain.